Tue, April 17, 2018
Mon, April 16, 2018
Fri, April 13, 2018
Thu, April 12, 2018
Wed, April 11, 2018
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018
Thu, March 29, 2018
Wed, March 28, 2018
Tue, March 27, 2018
Mon, March 26, 2018
Fri, March 23, 2018

Geoff Meacham Downgraded (BIIB) to Hold on, Apr 5th, 2018


//stocks-investing.news-articles.net/content/201 .. ham-downgraded-biib-to-hold-on-apr-5th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Geoff Meacham of Barclays, Downgraded "Biogen Inc." (BIIB) to Hold on, Apr 5th, 2018.

Geoff has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018


These are the ratings of the 5 analyists that currently disagree with Geoff


  • Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $393 on, Monday, March 5th, 2018
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
  • Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018

Publication Contributing Sources